News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
123,255 Results
Type
Article (6838)
Company Profile (25)
Press Release (116392)
Section
Business (38141)
Career Advice (146)
Deals (6103)
Drug Delivery (11)
Drug Development (8894)
Employer Resources (17)
FDA (3632)
Job Trends (2633)
News (57462)
Policy (4701)
Tag
Academia (417)
Alliances (12569)
Alzheimer's disease (332)
Approvals (3621)
Artificial intelligence (40)
Bankruptcy (48)
Best Places to Work (2110)
Breast cancer (26)
Cancer (221)
Career advice (133)
Clinical research (6753)
Collaboration (93)
COVID-19 (625)
C-suite (17)
Data (105)
Diabetes (17)
Diagnostics (5584)
Earnings (11899)
Employer resources (16)
Events (14938)
Executive appointments (43)
FDA (3705)
Funding (66)
Gene therapy (18)
GLP-1 (80)
Government (748)
Healthcare (3267)
Infectious disease (639)
Inflammatory bowel disease (19)
Interviews (15)
IPO (2067)
Job creations (573)
Job search strategy (126)
Layoffs (61)
Legal (704)
Liver cancer (22)
Lung cancer (31)
Manufacturing (35)
Medical device (2529)
Medtech (2529)
Mergers & acquisitions (4045)
Metabolic disorders (48)
Multiple sclerosis (17)
Neuroscience (370)
NextGen Class of 2024 (863)
Non-profit (668)
Northern California (210)
Obesity (27)
Opinion (30)
People (11369)
Phase I (2094)
Phase II (2858)
Phase III (2598)
Pipeline (27)
Postmarket research (372)
Preclinical (832)
Prostate cancer (19)
Radiopharmaceuticals (125)
Rare diseases (20)
Real estate (995)
Regulatory (3499)
Research institute (497)
Resumes & cover letters (20)
Southern California (162)
Startups (772)
United States (1888)
Vaccines (57)
Weight loss (22)
Date
Today (23)
Last 7 days (131)
Last 30 days (498)
Last 365 days (6218)
2024 (5236)
2023 (7125)
2022 (11774)
2021 (11160)
2020 (10458)
2019 (7225)
2018 (5754)
2017 (6239)
2016 (6171)
2015 (7165)
2014 (5304)
2013 (4685)
2012 (5108)
2011 (5425)
2010 (4898)
Location
Africa (167)
Arizona (42)
Asia (6214)
Australia (1346)
California (421)
Canada (167)
China (27)
Colorado (23)
Connecticut (23)
Europe (18161)
Florida (44)
Georgia (25)
Illinois (60)
Japan (14)
Maine (19)
Maryland (58)
Massachusetts (234)
Michigan (48)
Minnesota (64)
New Hampshire (16)
New Jersey (82)
New Mexico (15)
New York (207)
North Carolina (160)
Northern California (210)
Pennsylvania (54)
South America (189)
Southern California (162)
Texas (64)
Utah (42)
Virginia (19)
Washington State (102)
123,255 Results for "roche diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Roche announced that its whole-slide imaging system, the Roche Digital Pathology Dx, has received 510 clearance from the United States Food and Drug Administration.
June 18, 2024
·
3 min read
Weight loss
Roche’s Obesity Pill Candidate Hit With Safety Concerns Despite Strong Efficacy Data
When doses were increased rapidly in a Phase I study, patients on Roche’s investigational oral GLP-1 receptor agonist experienced nausea, vomiting, constipation, diarrhea, as well as abdominal distension.
September 12, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease
October 31, 2024
·
8 min read
Earnings
Roche Beats Q3 Sales Estimates as CEO Voices Opposition to Novo Holdings’ Catalent Buyout
Jefferies analyst Peter Welford noted that Roche’s pharma group came just slightly ahead of consensus expectations, driven by strong performance of its multiple sclerosis therapy Ocrevus and eye injection Vabysmo.
October 23, 2024
·
3 min read
·
Tristan Manalac
Immunology and inflammation
Roche Looks to Push Gazyva Into Lupus Nephritis With Promising Late-Stage Data
In the Phase III REGENCY study, Gazyva elicited superior complete renal response rates in patients with lupus nephritis versus placebo, positioning Roche’s therapeutic antibody for expansion into the indication.
September 27, 2024
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to work together on new treatments for the neurological disease.
October 22, 2024
·
1 min read
·
Annalee Armstrong
M&A
Roche Doubles Down on Breast Cancer With $850M for Regor’s CDK Inhibitors
The acquisition was featured Monday in Roche’s Pharma Day presentation, which also included projections of more than $3 billion in annual sales from three early-stage obesity and diabetes drugs.
September 30, 2024
·
2 min read
·
Heather McKenzie
Business
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
Roche announced that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration.
May 27, 2024
·
5 min read
News
Mindpeak Announces Collaboration With Roche to Enhance Cancer Diagnostics Through AI
September 16, 2024
·
1 min read
Approvals
Roche Gains PD-1 Edge on Merck With FDA Nod for Subcutaneous Tecentriq
Tecentriq Hybreza, which combines Roche’s Tecentriq with Halozyme Therapeutics’ Enhanze drug delivery technology, is being touted as the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy.
September 13, 2024
·
2 min read
·
Tristan Manalac
1 of 12,326
Next
